XTL Biopharmaceuticals Ltd ADR XTLB
Trading Information
- Previous Close Price
- $1.64
- Day Range
- $1.54–1.73
- 52-Week Range
- $0.00–5.64
- Bid/Ask
- $1.54 / $1.78
- Shares Outstanding
- 2.46M
- Market Cap
- $3.93M
- Volume/Avg
- 5,956 / 8,375
Key Statistics
- Price/Earnings (Normalized)
- 0.69
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 5
- Website
- https://www.xtlbio.com
Valuation
Metric | XTLB |
|---|---|
Price/Earnings (Normalized) | 0.69 |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
XTLB
Financial Strength
Metric | XTLB |
|---|---|
Quick Ratio | 0.34 |
Current Ratio | 0.40 |
Interest Coverage | −116.00 |
Quick Ratio
XTLB
Profitability
Metric | XTLB |
|---|---|
Return on Assets (Normalized) | 166.10% |
Return on Equity (Normalized) | 305.08% |
Return on Invested Capital (Normalized) | 275.53% |
Return on Assets
XTLB
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|#H%j@& | LOCK|^k>^^ | $137B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|tR>>grQ | LOCK|$>ZB | $99B | |||
| Moderna Inc MRNA | LOCK|$t<<zn> | LOCK|$bF | $90B | |||
| argenx SE ADR ARGX | LOCK|zp!Tnn^ | LOCK|GN | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|%g#nz< | LOCK|Rh | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|^psBJ<?D | LOCK|dBh<? | $31B | |||
| Incyte Corp INCY | LOCK|m>MN>C& | LOCK|Hyd | $25B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|gsR%bz | LOCK|H^$XY | $22B | |||
| BioNTech SE ADR BNTX | LOCK|?mYbN#H | LOCK|QV! | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|ZsfgQl$ | LOCK|&$ | $16B |
United States